Transvaginal Mesh Implants

FDA’s Medical Device Chief Calls For More Power To Block Unsafe Products Such As Transvaginal Mesh Implants

According to Jeffrey Shuren, director of the FDA’s Center for Devices and Radiological Health, the Food and Drug Administration (FDA) needs more power to block unsafe products, and prevent repeats of faulty hip implants and vaginal mesh that have sparked thousands of patient lawsuits. According to him, the FDA now lacks that authority in many [...]

Continue reading...

Transvaginal Mesh For The Treatment Of POP Should Be Limited To High-Risk Women

Just yesterday, Joint Committee Opinion issued by the American College of Obstetricians and Gynecologists (ACOG) and the American Urogynecologic Society (AUGS), recommended that the use of transvaginal mesh for the treatment of pelvic organ prolapse (POP) be limited to high-risk women for whom the benefit may justify the risk. Additionally, the Joint Committee recommended that [...]

Continue reading...